E. Richards

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke ( RIGHT-2 ) : an ambulance-based , randomised , sham-controlled , blinded , phase 3 trial

Peter J. Godolphin, P. Sandercock, C. Anderson, 2019 .

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

S. M. Park, M. N. Duy, Le Tuan Linh, 2019, Lancet.

Long-term results of a randomised trial comparing regimens of cyclophosphamide and fluorouracil with either mitoxantrone or doxorubicin in patients with advanced breast cancer.

P. Pouillart, J. Follezou, T. Palangié, 1994, European journal of cancer.

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas

A. Ho, W. Bezwoda, J. Diaz-Maqueo, 1995 .

Abstract CT101: A model-based exposure-response (E-R) assessment of a nivolumab (NIVO) 4-weekly (Q4W) dosing schedule across multiple tumor types

V. Ivaturi, V. Goodman, J. Gobburu, 2017 .

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

P. Sandercock, C. Anderson, P. Rothwell, 2019, Lancet.